Sağlık Teknolojisi
Arjantin Şirketleri tek bir sektörde faaliyet göstermektedir:sağlık teknolojisi
Bu Arjantin Şirketleri aynı sektörde, sağlık teknolojisi, faaliyet göstermektedir. En fazla ayrıntıyı almanıza yardımcı olmak için fiyat, değişim ve diğer istatistiklerle donatılmıştır. Liste her stratejiye uygun hisse senetleri içerir: ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 gibi büyük sermayeli devler, NOVARTIS AG CEDEAR EAC 4 REP 1(USD) gibi en çok kazananlar ve daha fazlası. Listeyi filtreleyin ve şirketlerin performansını uygun bir şekilde kontrol edin.
Sembol | Piyasa Değeri | Fiyat | Değişim % | Hacim | Bağ Hacim | FKO | EPS Seyreltilmiş TTM | EPS Seyreltilmiş Büyüme TTM YY | Tmt getirisi % TTM | Analist Değerlendirmesi |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 617.253 T ARS | 13828.500 ARS | −2.54% | 2.71 K | 1.28 | — | — | — | — | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 617.253 T ARS | 13.200 USD | −5.71% | 6 | 0.06 | — | — | — | — | — |
 DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)DR | 305.659 T ARS | 1168.000 ARS | −2.42% | 11 | 0.00 | — | — | — | — | — |
| JNJ.BJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 305.659 T ARS | 10500.000 ARS | −20.99% | 2.511 K | 0.07 | 43.23 | 242.90 ARS | +459.57% | 0.88% | — |
| DJN3BJOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 305.659 T ARS | 1147.500 ARS | +0.48% | 1 M | 2.65 | — | — | — | — | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 305.659 T ARS | 10539.000 ARS | +1.86% | 12.318 K | 0.77 | 43.39 | 242.90 ARS | +459.57% | 0.88% | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 305.659 T ARS | 10.300 USD | −0.96% | 383 | 0.45 | 36.31 | 242.90 ARS | +48.88% | 0.88% | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 276.034 T ARS | 26865.500 ARS | +0.81% | 1.037 K | 1.85 | — | — | — | — | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 276.034 T ARS | 26.000 USD | 0.00% | 20 | 4.08 | — | — | — | — | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 253.747 T ARS | 17784.000 ARS | +1.09% | 477 | 0.22 | 22.15 | 802.79 ARS | −6.12% | 1.00% | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 253.747 T ARS | 17.350 USD | −2.25% | 35 | 0.29 | 17.47 | 802.79 ARS | −77.92% | 1.00% | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 183.152 T ARS | 36762.500 ARS | +1.01% | 6.577 K | 12.89 | 176.76 | 207.98 ARS | +257.80% | 1.17% | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 183.152 T ARS | 36.750 USD | −0.27% | 5 | 0.70 | 142.85 | 207.98 ARS | −15.86% | 1.17% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 179.901 T ARS | 26417.000 ARS | +1.21% | 3 | 0.02 | — | — | — | — | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 159.63 T ARS | 25364.500 ARS | +2.82% | 213 | 4.52 | — | — | — | — | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 159.63 T ARS | 24.250 USD | +4.98% | 2 | 0.34 | — | — | — | — | — |
 ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1DR | 158.975 T ARS | 28589.000 ARS | +2.40% | 223 | 0.29 | 80.40 | 355.57 ARS | +193.15% | 0.55% | — |
| ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) DR | 158.975 T ARS | 28.000 USD | 0.00% | 1 | 0.10 | 67.42 | 355.57 ARS | −22.00% | 0.55% | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 124.78 T ARS | 6965.500 ARS | +3.43% | 15.7 K | 0.66 | — | — | — | — | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 124.78 T ARS | 6.890 USD | +1.77% | 637 | 0.81 | — | — | — | — | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 122.552 T ARS | 9573.500 ARS | +2.54% | 906 | 0.70 | — | — | — | — | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 122.552 T ARS | 9.400 USD | 0.00% | 6 | 0.12 | — | — | — | — | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 91.515 T ARS | 21242.500 ARS | +1.19% | 293 | 3.61 | — | — | — | — | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 85.198 T ARS | 17544.500 ARS | +2.11% | 617 | 1.80 | — | — | — | — | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 85.198 T ARS | 17.500 USD | +2.04% | 6 | — | — | — | — | — | — |
 GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001DR | 71.801 T ARS | 17796.500 ARS | +1.15% | 188 | 0.42 | — | — | — | — | — |
| GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD) DR | 71.801 T ARS | 16.800 USD | +0.60% | 9 | 0.64 | — | — | — | — | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 70.641 T ARS | 10647.500 ARS | +2.02% | 279 | 1.21 | 54.80 | 194.30 ARS | −31.41% | 1.42% | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 70.641 T ARS | 10.200 USD | −8.52% | 100 | 5.21 | 42.44 | 194.30 ARS | −83.87% | 1.42% | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 24.103 T ARS | 15933.500 ARS | +1.81% | 878 | 2.16 | — | — | — | — | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 24.103 T ARS | 20.000 USD | +2.04% | 18 | 2.69 | — | — | — | — | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 15.907 T ARS | 4289.000 ARS | +1.04% | 696 | 0.51 | — | — | — | — | — |
 RICHLABORATORIOS RICHMOND SACIF | 70.496 B ARS | 874.500 ARS | +0.17% | 7.057 K | 0.74 | — | −130.78 ARS | — | 0.00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4.344 B ARS | 97.500 ARS | −4.41% | 2.006 K | 0.32 | — | — | — | 0.00% | — |